Built by doctors.
Pristene started in a physician's exam room — not a marketing meeting. Our team believed patients could get better dietary supplementation, built on hard science.
So they created the products they'd take themselves — dosed to the AREDS2® levels that actually move the needle — because our patients and customers deserve nothing less.
Four tenets. Every batch.
Doctor formulated
Built in clinical practice by an MD, not a marketing brief.
Clinically dosed
25 mg pure lutein — 2.5× more than most brands, undiluted.
Verified every batch
cGMP-certified and third-party tested to the milligram.
Made in the USA
A promise and commitment to patient satisfaction.
The formula we recommend to our own patients — now yours to take every day.
A team of experts
Meet the group of talented people — physicians, scientists and operators — behind Pristene.
Medical advisory board members are investors or option holders in Pristene
Tony Moses
Serves as CEO of Eyecheck, bringing over 35 years of experience in ophthalmology. Previously VP of Sales at Second Sight, VP of Global Sales at Oraya Therapeutics, and Global Commercial VP at Neovista, beginning his career at Storz Instruments.
Rama Jager
Rama D. Jager, M.D., M.B.A., F.A.C.S. is the founder of Eyecheck. He is a board-certified ophthalmologist and vitreoretinal surgeon. He is the founder of University Retina and also serves as a Clinical Professor of Ophthalmology at the University of Illinois at Chicago (UIC).
John Mahoney
General counsel for Eyecheck and President of John Francis Mahoney Law, Ltd., with 25+ years as a CPA and lawyer focused on business formation, taxation and governance. A University of Michigan Law graduate, he began at Price Waterhouse.
Torsten Kuehn
A venture capitalist focused on the life-sciences industry. His hybrid investment strategy supports expansion-oriented companies with capital and connections to European distribution partners.
Ram Palanki
Dr. Ram Palanki has nearly 20 years of experience in the development and commercialization of biopharmaceuticals and medical devices. Before joining REGENXBIO, Dr. Palanki was Senior Vice President of Commercial for the Americas at Santen Inc. Previously, he served as the executive team member leading the strategy and operations for pre-launch and global commercialization of a first-in-class biologic at ThromboGenics.
Rohit Varma
Dr. Rohit Varma is founding director of Southern California Eye Institute (SCEI) and is former Dean of the Keck School of Medicine of the University of Southern California (USC) and the former Grace and Emery Beardsley Chair in Ophthalmology and the former chair of the Illinois Eye and Ear Infirmary at the University of Illinois at Chicago.
Peter Kaiser
Peter K. Kaiser, MD, is the Chief Development Officer of Ocular Therapeutix and currently serves on the vitreoretinal faculty of the Cole Eye Institute in the Department of Ophthalmology at the Cleveland Clinic.
Sai Chavala
Professor at the North Texas Eye Research Institute specializing in retinal repair using stem cells. Trained at Cleveland Clinic, Cornell and Duke, he has contributed to over 75 scholarly works.
Subhransu Ray
Harvard-trained, he served as Chief Resident and Director of Eye Trauma. Specializing in retinal disease, he conducts clinical trials and develops treatments for diabetes-related eye conditions.
We're here to help
Questions about your routine, an order, or which formula is right for you? Our team is glad to help.
Care for your eyes, the Pristene way.
Discover the physician-formulated routine behind the mission — free shipping and a 60-day money-back guarantee on every order.
Shop all formulas